Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) Non Operating Income (2016 - 2024)

Trinity Biotech's Non Operating Income history spans 11 years, with the latest figure at $6.5 million for Q4 2024.

  • On a quarterly basis, Non Operating Income rose 473.87% to $6.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.4 million, a 113.98% increase, with the full-year FY2025 number at $202000.0, down 82.76% from a year prior.
  • Non Operating Income hit $6.5 million in Q4 2024 for Trinity Biotech, up from -$2.2 million in the prior quarter.
  • Over the last five years, Non Operating Income for TRIB hit a ceiling of $6.5 million in Q4 2024 and a floor of -$12.0 million in Q1 2022.
  • Historically, Non Operating Income has averaged -$2.7 million across 4 years, with a median of -$2.1 million in 2023.
  • Biggest five-year swings in Non Operating Income: tumbled 58.95% in 2022 and later skyrocketed 473.87% in 2024.
  • Tracing TRIB's Non Operating Income over 4 years: stood at -$1.2 million in 2021, then tumbled by 58.95% to -$1.9 million in 2022, then grew by 6.95% to -$1.7 million in 2023, then skyrocketed by 473.87% to $6.5 million in 2024.
  • Business Quant data shows Non Operating Income for TRIB at $6.5 million in Q4 2024, -$2.2 million in Q3 2024, and -$2.8 million in Q2 2024.